 "Jubilant Life Sciences")
Shares of Jubilant Life Sciences surged over 12% in trade on Wednesday after the company's consolidated net profit zoomed nearly 14-fold to Rs 149.03 crore in the March quarter on robust sales.
The company had posted a net profit of Rs 10.86 crore for the corresponding period of the previous fiscal year.
Reacting to its earnings, the stock advanced as much as 12.5% to Rs 762 on the BSE.
Over 3 lakh shares of the scrip exchanged hands on the BSE so far against its two-week average of 50,000 shares.
The company's consolidated total revenue from operations rose to Rs 1,641.42 crore for the
